Puma paediatric use marketing authorisation
WebLittle use has been made of the other rewards provided by the Paediatric Regulation, the orphan reward, or the PUMA (paediatric use marketing authorisation) scheme. The analysis showed that the Regulation has had a positive effect overall in gradually helping to reduce off-label use of adult medicines in children. WebApr 14, 2024 · Pedmarqsi (sodium thiosulfate): received a positive opinion for a paediatric-use marketing authorisation (PUMA) is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
Puma paediatric use marketing authorisation
Did you know?
WebPUMA abbreviation stands for paediatric-use marketing authorisation. Suggest. PUMA means paediatric-use marketing authorisation. Abbreviation is mostly ... Most relevant … WebJan 26, 2008 · The option of marketing a special paediatric medicinal product (Paediatric Use Marketing Authorisation - PUMA) is created for existing medicinal products. A …
WebAt Proveca we develop and license medicines for children with a core focus on treatments within cerebral palsy, epilepsy and heart failure.We have also collaborated with the European Medicine Agency’s Paediatric Committee to gain a Paediatric-Use Marketing Authorisation (PUMA) for the symptomatic treatment of severe sialorrhoea (chronic drooling) in …
WebTherefore, the paediatric use marketing authorisation (PUMA) has been designed. The EMA Paediatric Working Party has prioritized the unmet need for the cardiovascular off-patent … WebJul 6, 2024 · Biopharmaceutical companies and regulators across Europe have said that in the 10 years since the Pediatric Regulation took effect, some pediatric therapeutic areas …
WebThe Paediatric Use Marketing Authorisation (PUMA) (4) the name of the product granted a PUMA can utilise the existing brand name of the corresponding product but will display a …
WebPUMA. Paediatric Use Marketing Authorisation . Other definitions. PMCPA. Prescription Medicines Code of Practice Authority . PAR. Public Assessment Report . PUT-RD. Protocol … nuffield health login emailWebClause: EU marketing authorisation. Contract Type. Jurisdiction. Country. Include Keywords. Exclude Keywords. Additional filters are available in search. Open Search. Remove … ningxia beilite chemicalWebFeb 13, 2024 · Diurnal’s first product to receive marketing authorisation. Market launch anticipated in Q2 2024. Diurnal Group plc (AIM: ... needs in chronic endocrine (hormonal) … ningxia and diabetesWebNov 1, 2012 · Request PDF On Nov 1, 2012, D. Gladwell and others published PHP193 Paediatric Use Marketing Authorisation (PUMA): The Challenges of Cost-Effectiveness … ningxia and sulfurzymeWebList of information about Marketing authorisations, variations and licensing guidance. Medicines, medical devices and blood regulation and safety: Marketing authorisations, … ningwood stationWebApr 14, 2024 · Pedmarqsi (sodium thiosulfate): received a positive opinion for a paediatric-use marketing authorisation (PUMA) is indicated for the prevention of ototoxicity induced … nuffield health liverpoolWebIn order to do so, the regulation provides for paediatric use marketing authorisations (PUMA) for previously authorised products no longer covered by intellectual property … nuffieldhealth logo